Sheila Grab,BS, a PittPharmacy graduate student, received a TL-1 pre-doctoral fellowship award from the Clinical and Translational Sciences Institute of the University of Pittsburgh (CTSI). As part of the fellowship, which aims to prepare investigators for a career in clinical and translational sciences, Grab will participate in a multi-faceted career development program including didactic education, career coaching and mentored research. As part of her PhD dissertation work, Grab is investigating the development of polymeric films to deliver HIV preventative microbicides. Grab is mentored by PittPharmacy Professor Lisa Rohan, PhD and Pitt School of Medicine faculty Charlene Dezzutti, PhD.
Fanuel Hagos, a PittPharmacy graduate student, received a TL-1 pre-doctoral fellowship award from the Clinical and Translational Sciences Institute of the University of Pittsburgh (CTSI). As part of the fellowship, which aims to prepare investigators for a career in clinical and translational sciences, Hagos will participate in a multi-faceted career development program including didactic education, career coaching and mentored research. As part of his PhD dissertation work, Hagos is investigating how membrane transporters that are expressed in the central nervous system affect the pathophysiology and pharmacotherapy of traumatic brain injury. Hagos is mentored by PittPharmacy Assistant Professor Philip Empey, PharmD, PhD.
Alexander J. Prokopienko, PharmD, a PittPharmacy graduate student, received a TL-1 post-doctoral (Clinical and Translational Science) fellowship award from the Clinical and Translational Sciences Institute of the University of Pittsburgh (CTSI). As part of the fellowship, which aims to prepare investigators for a career in clinical and translational sciences, Prokopienko will participate in a multi-faceted career development program including didactic education, career coaching and mentored research. As part of his PhD dissertation work, Prokopienko is investigating the effects of kidney disease on drug metabolism and the human microbiome. The long-term goal is to evaluate novel therapeutic strategies to reduce cardiovascular disease. Prokopienko is mentored by PittPharmacy Associate Professor Thomas D. Nolin, PharmD, PhD.
